President Donald Trump is planning to dismiss U.S. Food and Drug Administration Commissioner Marty Makary, according to sources familiar with the matter, though the plan is not yet final and could still change.
Makary, who was confirmed as FDA commissioner in March 2025, is a surgical oncologist affiliated with the Johns Hopkins University School of Medicine. In addition to his clinical work, he has authored bestselling books that focus on healthcare costs and what he has described as the shortcomings of modern medicine.
He has been an active proponent of Health and Human Services Secretary Robert F. Kennedy’s Make America Healthy Again movement, playing a visible role in advocating for the initiative. The HHS, the federal department responsible for oversight of the FDA, did not immediately respond to a request for comment.
Over the past week, chatter about a possible departure by Makary has become more pronounced, drawing expanded attention and prompting wider speculation about the FDA leadership. Observers noted that the matter remains fluid given the report that the removal plan is not yet settled and may be altered.
Context and current status
The available information indicates that officials are weighing action to replace the FDA commissioner, but that no definitive decision has been announced. The description that the plan is not final underscores ongoing uncertainty about next steps.
Profile of the commissioner
- Marty Makary was confirmed as FDA commissioner in March 2025.
- He is a surgical oncologist at the Johns Hopkins University School of Medicine.
- Makary has written bestselling books about healthcare costs and perceived failures in modern medicine.
- He has been a key advocate of HHS Secretary Robert F. Kennedy’s Make America Healthy Again movement.
Developments to watch
- Whether the reported plan to remove the commissioner is carried out or altered.
- Any official comment or confirmation from HHS regarding personnel changes at the FDA.
- How continued speculation may influence stakeholders in healthcare and regulated industries.